Enzolytics Inc (ENZC)

[foxi]

GreenLight's covid treatment is mRNA and ENZC's is monoclonal antibodies. ENZC's antibodies target covid immutable sites so in theory its mAbs would work against most or all covid variants. Two different technologies, and there's room in the markets for both.

For both companies, it's critical to deliver results in clinical trials while the market opportunity is there.